Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.

A new review highlights how machine learning is transforming the way scientists detect and measure organic pollutants in the ...

Yale researchers have developed a machine learning model, called Immunostruct, that can help scientists create more ...

New research on 175,000 women—the largest NHS study to date—on the use of AI in breast cancer screening shows that AI ...

Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) and has become a powerful tool in the diagnosis and treatment of solid tumors. Current applications ...

The field of immunology has long recognized immune system dysregulation as a cornerstone of pathogenesis across a range of human diseases, including ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

Cancer is often difficult to detect in its early stages. Biomarkers that can reveal the disease are present only in very small amounts in the blood. As a result, many tests today require additional ...

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes.